AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review
Authors
Keywords
-
Journal
BIOCHEMICAL PHARMACOLOGY
Volume -, Issue -, Pages 115871
Publisher
Elsevier BV
Online
2023-10-20
DOI
10.1016/j.bcp.2023.115871
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- (2023) Mary E. Rinella et al. HEPATOLOGY
- Screening for MAFLD: who, when and how?
- (2023) Shreya C. Pal et al. Therapeutic Advances in Endocrinology and Metabolism
- Treatment of obesity and metabolic-associated fatty liver disease with a diet or orlistat: A randomized controlled trial
- (2023) Xiongcai Feng et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease
- (2023) Cailin Wang et al. EXPERIMENTAL NEUROLOGY
- How far are we from an approved drug for nonalcoholic steatohepatitis?
- (2023) Nahum Méndez-Sánchez et al. EXPERT OPINION ON PHARMACOTHERAPY
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. HEPATOLOGY
- Anti-Inflammatory Effects of Adiponectin Receptor Agonist AdipoRon against Intervertebral Disc Degeneration
- (2023) Hiroki Ohnishi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Unraveling the Role of Adiponectin Receptors in Obesity-Related Breast Cancer
- (2023) Giuseppina Daniela Naimo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin Enhances Fatty Acid Signaling in Human Taste Cells by Increasing Surface Expression of CD36
- (2023) Fangjun Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AdipoRon alleviates fatty acid–induced lipid accumulation and mitochondrial dysfunction in bovine hepatocytes by promoting autophagy
- (2023) Chenchen Zhao et al. JOURNAL OF DAIRY SCIENCE
- Antioxidant Peptides from Monkfish Swim Bladders: Ameliorating NAFLD In Vitro by Suppressing Lipid Accumulation and Oxidative Stress via Regulating AMPK/Nrf2 Pathway
- (2023) Ming-Feng Wu et al. Marine Drugs
- The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis
- (2023) Harold I. Salmons et al. Tissue Engineering Part C-Methods
- Organokines in COVID-19: A Systematic Review
- (2023) Sandra Maria Barbalho et al. Cells
- The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
- (2023) Li Qin et al. Frontiers in Cardiovascular Medicine
- Assessment of Auricularia cornea var. Li. polysaccharides potential to improve hepatic, antioxidation and intestinal microecology in rats with non-alcoholic fatty liver disease
- (2023) Tiantian Zhou et al. Frontiers in Nutrition
- Hepatic MCPIP1 protein levels are reduced in NAFLD patients and are predominantly expressed in cholangiocytes and liver endothelium
- (2023) Natalia Pydyn et al. Hepatology Communications
- Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1
- (2023) Mingming Qi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adipose tissue dysfunction serum markers are associated with high density lipoprotein size and glycation in the early stages of type 2 diabetes
- (2023) Esteban Jorge-Galarza et al. Lipids in Health and Disease
- The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
- (2023) Ilias D. Vachliotis et al. Current Obesity Reports
- Development, validation, and application of an UHPLC‐MS/MS method for quantification of the adiponectin‐derived active peptide ADP355 in rat plasma
- (2022) Qiaoxi Li et al. BIOMEDICAL CHROMATOGRAPHY
- Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory
- (2022) Hartmut Beck et al. DRUG DISCOVERY TODAY
- Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
- (2022) João Paulo Margiotti dos Santos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming
- (2022) Duc-Vinh Pham et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen‐activated protein kinase
- (2022) Yunjing Yan et al. JOURNAL OF PATHOLOGY
- Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells
- (2022) Sharon J. Manley et al. Cell Death & Disease
- Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
- (2022) Angela Ragone et al. Frontiers in Pharmacology
- Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure
- (2022) Di Zhu et al. CIRCULATION RESEARCH
- Role of Leptin and Adiponectin in Endometrial Cancer
- (2022) Aneta Słabuszewska-Jóźwiak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective effects of AdipoRon on the liver of Huoyan goose fed a high-fat diet
- (2022) Zhongzan Cao et al. POULTRY SCIENCE
- Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss
- (2022) Sjaak Pouwels et al. BMC Endocrine Disorders
- Global multi-stakeholder endorsement of the MAFLD definition
- (2022) Nahum Méndez-Sánchez et al. Lancet Gastroenterology & Hepatology
- RELATIONSHIP OF SERUM ADIPONECTIN LEVELS WITH GLYCAEMIC STATUS IN PREGNANT WOMEN
- (2022) Yasmin Akhtar et al. Journal of Ayub Medical College, Abbottabad : JAMC
- Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
- (2022) Meenakshi Vachher et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
- (2022) Jin G. Choi et al. ANNALS OF INTERNAL MEDICINE
- Metabolic switch in cancer – Survival of the fittest
- (2022) Hans Raskov et al. EUROPEAN JOURNAL OF CANCER
- Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis
- (2022) Liang Dai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- AdipoRon enhances healthspan in middle‐aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers
- (2022) Camille M. Selvais et al. Journal of Cachexia Sarcopenia and Muscle
- Globular adiponectin ameliorates insulin resistance in skeletal muscle by enhancing the LKB1-mediated AMPK activation via SESN2
- (2022) Xinmeng Liu et al. Sports Medicine and Health Science
- Pathophysiology of NASH in endocrine diseases
- (2021) Karim Gariani et al. Endocrine Connections
- Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
- (2021) Ana Rita de Oliveira dos Santos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice
- (2021) Keizo Takenaga et al. Scientific Reports
- miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3
- (2021) Qian Zhang et al. LIFE SCIENCES
- Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition
- (2021) Kayvan Khoramipour et al. Nutrients
- AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
- (2021) Ersilia Nigro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PEGylated AdipoRon derivatives improve glucose and lipid metabolism under insulinopenic and high fat diet conditions
- (2021) Toshiharu Onodera et al. JOURNAL OF LIPID RESEARCH
- The bifurcated role of adiponectin in colorectal cancer
- (2021) Debrup Chakraborty et al. LIFE SCIENCES
- Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway
- (2021) Xiaohong Xu et al. BMC Nephrology
- Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
- (2021) João Leonardo Silveira Rossi et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice
- (2020) Min Sha et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases
- (2020) Hyung Muk Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells
- (2020) Luigi Sapio et al. Journal of Oncology
- Adiponectin-Based Peptide (ADP355) Inhibits Transforming Growth Factor-β1-Induced Fibrosis in Keloids
- (2020) Claudia C. Darmawan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β
- (2020) Haixiao Liu et al. EXPERIMENTAL NEUROLOGY
- Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines
- (2020) Ben Kirk et al. Current Osteoporosis Reports
- Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress
- (2020) Dan Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adiponectin receptor activation inhibits prostate cancer xenograft growth
- (2020) Lisa K Philp et al. ENDOCRINE-RELATED CANCER
- Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
- (2020) Xiruo Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The liver as an endocrine organ - linking NAFLD and insulin resistance
- (2019) Matthew J Watt et al. ENDOCRINE REVIEWS
- Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells
- (2019) Amin A. Ramzan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Potential Adiponectin Receptor Response Modifier Therapeutics
- (2019) Laszlo Otvos Frontiers in Endocrinology
- Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
- (2019) Wen-Ze Xiao et al. CHINESE MEDICAL JOURNAL
- Discovery of a novel potent peptide agonist to adiponectin receptor 1
- (2018) Sunghwan Kim et al. PLoS One
- Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis
- (2018) Miho Akimoto et al. Cell Death & Disease
- Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin
- (2017) Simon Jasinski-Bergner et al. Obesity Facts
- Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients
- (2017) Ming-Chun Chen et al. Diabetology & Metabolic Syndrome
- Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
- (2017) Fanuel Messaggio et al. Oncotarget
- Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice
- (2016) Ying Wang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Adiponectin, the past two decades
- (2016) Zhao V. Wang et al. Journal of Molecular Cell Biology
- Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury
- (2016) Huafeng Wang et al. Scientific Reports
- The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
- (2015) Sílvia S. Chambel et al. Biomed Research International
- Modulation of adiponectin as a potential therapeutic strategy
- (2014) Soo Lim et al. ATHEROSCLEROSIS
- Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis
- (2014) Pradeep Kumar et al. FASEB JOURNAL
- Adiponectin Agonist ADP355 Attenuates CCl4-Induced Liver Fibrosis in Mice
- (2014) Pradeep Kumar et al. PLoS One
- A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
- (2013) Miki Okada-Iwabu et al. NATURE
- Adiponectin Provides Additional Information to Conventional Cardiovascular Risk Factors for Assessing the Risk of Atherosclerosis in Both Genders
- (2013) Jin-Ha Yoon et al. PLoS One
- Design and development of a peptide-based adiponectin receptor agonist for cancer treatment
- (2011) Laszlo Otvos et al. BMC BIOTECHNOLOGY
- Access to gram scale amounts of functional globular adiponectin from E. coli inclusion bodies by alkaline-shock solubilization
- (2010) John T. Heiker et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- APPL1: role in adiponectin signaling and beyond
- (2008) Sathyaseelan S. Deepa et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Adiponectin stimulates phosphorylation of AMP-activated protein kinase α in renal glomeruli
- (2008) Philippe G. Cammisotto et al. JOURNAL OF MOLECULAR HISTOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now